Skip to main content
. 2017 Sep 28;58(11):2210–2219. doi: 10.1194/jlr.D073197

Fig. 4.

Fig. 4.

Clinical validation of NRQ. A, B: LD-positive monocytes (A) and LDs per LD-positive monocyte (B) in FH patients. C, D: LD-positive monocytes (C) and LDs per LD-positive monocyte (D) before and 4 h after oral fat administration. P < 0.05 considered significant. Data are shown as mean ± SD for n = 3 patients per group.